94 related articles for article (PubMed ID: 25260954)
1. Fatigue and carnitine levels over multiple cycles of chemotherapy in children and adolescents.
Hooke MC; McCarthy K; Taylor O; Hockenberry MJ
Eur J Oncol Nurs; 2015 Feb; 19(1):7-12. PubMed ID: 25260954
[TBL] [Abstract][Full Text] [Related]
2. Carnitine plasma levels and fatigue in children/adolescents receiving cisplatin, ifosfamide, or doxorubicin.
Hockenberry MJ; Hooke MC; Gregurich M; McCarthy K
J Pediatr Hematol Oncol; 2009 Sep; 31(9):664-9. PubMed ID: 19707160
[TBL] [Abstract][Full Text] [Related]
3. Symptom clusters in children and adolescents receiving cisplatin, doxorubicin, or ifosfamide.
Hockenberry MJ; Hooke MC; Gregurich M; McCarthy K; Sambuco G; Krull K
Oncol Nurs Forum; 2010 Jan; 37(1):E16-27. PubMed ID: 20044328
[TBL] [Abstract][Full Text] [Related]
4. Relationship between Carnitine Pharmacokinetics and Fatigue in Patients Treated with Cisplatin-Containing Chemotherapy.
Ikezaki T; Suzuki K; Kambara K; Inomata M; Okazawa S; Kajiura S; Miwa T; Tanabe K; Kashii T
Oncol Res Treat; 2017; 40(1-2):42-45. PubMed ID: 28118647
[TBL] [Abstract][Full Text] [Related]
5. Sickness behavior clustering in children with cancer.
Hockenberry MJ; Hooke MC; McCarthy K; Gregurich MA
J Pediatr Oncol Nurs; 2011; 28(5):263-72. PubMed ID: 21946193
[TBL] [Abstract][Full Text] [Related]
6. A cross-sectional study of carnitine deficiency and fatigue in pediatric cancer patients.
Lai JS; Haertling T; Weinstein J; Rademaker AW; Goldman S
Childs Nerv Syst; 2016 Mar; 32(3):475-83. PubMed ID: 26812488
[TBL] [Abstract][Full Text] [Related]
7. Fatigue and physical performance in children and adolescents receiving chemotherapy.
Hooke MC; Garwick AW; Gross CR
Oncol Nurs Forum; 2011 Nov; 38(6):649-57. PubMed ID: 22037328
[TBL] [Abstract][Full Text] [Related]
8. Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients.
Graziano F; Bisonni R; Catalano V; Silva R; Rovidati S; Mencarini E; Ferraro B; Canestrari F; Baldelli AM; De Gaetano A; Giordani P; Testa E; Lai V
Br J Cancer; 2002 Jun; 86(12):1854-7. PubMed ID: 12085175
[TBL] [Abstract][Full Text] [Related]
9. Safety, tolerability and symptom outcomes associated with L-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I/II study.
Cruciani RA; Dvorkin E; Homel P; Malamud S; Culliney B; Lapin J; Portenoy RK; Esteban-Cruciani N
J Pain Symptom Manage; 2006 Dec; 32(6):551-9. PubMed ID: 17157757
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy.
Gramignano G; Lusso MR; Madeddu C; Massa E; Serpe R; Deiana L; Lamonica G; Dessì M; Spiga C; Astara G; Macciò A; Mantovani G
Nutrition; 2006 Feb; 22(2):136-45. PubMed ID: 16459226
[TBL] [Abstract][Full Text] [Related]
12. Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy.
Jacobsen PB; Garland LL; Booth-Jones M; Donovan KA; Thors CL; Winters E; Grendys E
J Pain Symptom Manage; 2004 Jul; 28(1):7-18. PubMed ID: 15223080
[TBL] [Abstract][Full Text] [Related]
13. Cancer-related fatigue and chemotherapy-associated adverse effects: correlation with TNF-α, IL-1 and 17-hydroxycorticosteroids.
Zhang S; Zeng D; Peng Y; Yang Y; Zhuang X; Li Z; Wang M; Chen L; Zhang H
Future Oncol; 2014; 10(9):1619-26. PubMed ID: 24450574
[TBL] [Abstract][Full Text] [Related]
14. Determining and surveying the role of carnitine and folic acid to decrease fatigue in β-thalassemia minor subjects.
Tabei SM; Mazloom M; Shahriari M; Zareifar S; Azimi A; Hadaegh A; Karimi M
Pediatr Hematol Oncol; 2013 Nov; 30(8):742-7. PubMed ID: 23458634
[TBL] [Abstract][Full Text] [Related]
15. Repeated Combined Chemotherapy with Cisplatin Lowers Carnitine Levels in Gastric Cancer Patients.
Kawai A; Matsumoto H; Endou Y; Honda Y; Kubota H; Higashida M; Hirai T
Ann Nutr Metab; 2017; 71(3-4):261-265. PubMed ID: 29237151
[TBL] [Abstract][Full Text] [Related]
16. Carnitine is associated with fatigue following chemoradiotherapy for head and neck cancer.
Endo K; Tsuji A; Kondo S; Wakisaka N; Murono S; Yoshizaki T
Acta Otolaryngol; 2015 Aug; 135(8):846-52. PubMed ID: 25828505
[TBL] [Abstract][Full Text] [Related]
17. Carnitine deficiency during valproic acid treatment.
Van Wouwe JP
Int J Vitam Nutr Res; 1995; 65(3):211-4. PubMed ID: 8830002
[TBL] [Abstract][Full Text] [Related]
18. Serum carnitine levels in childhood leukemia.
Rogalidou M; Evangeliou A; Stiakaki E; Giahnakis E; Kalmanti M
J Pediatr Hematol Oncol; 2010 Mar; 32(2):e61-9. PubMed ID: 20168247
[TBL] [Abstract][Full Text] [Related]
19. Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma.
Chamberlain MC; Glantz MJ
Neurosurgery; 2008 Oct; 63(4):720-6; author reply 726-7. PubMed ID: 18981882
[TBL] [Abstract][Full Text] [Related]
20. Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy.
Berger AM
Oncol Nurs Forum; 1998; 25(1):51-62. PubMed ID: 9460773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
